Related Experiment Video
Updated: Sep 7, 2025

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
Inhibitory Effect of Mitoxantrone on Collagen Synthesis in Dermal Fibroblasts
Kyung-Il Kim1,2,3, Chang-Il Kwon3,4, Jeung-Hoon Lee5
1Department of Dermatology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
Background:
Fibroblasts produce collagen molecules that support the structure of the skin. The decrease and hypersynthesis of collagen causes skin problems such as skin atrophy, wrinkles and scars.
Objective:
The purpose of this study is to investigate the mechanism of mitoxantrone on collagen synthesis in fibroblasts.
Methods:
Cultured fibroblasts were treated with mitoxantrone, and then collagen synthesis was confirmed by reverse transcription-polymerase chain reaction and Western blot.
Results:
Mitoxantrone inhibited the expression of type I collagen in fibroblasts at both the mRNA and protein levels. In the collagen gel contraction assay, mitoxantrone significantly inhibited gel contraction compared to the control group. Mitoxantrone inhibited transforming growth factor (TGF)-β-induced phosphorylation of SMAD3. Finally, mitoxantrone inhibited the expression of LARP6, an RNA-binding protein that regulates collagen mRNA stability.
Conclusion:
These results suggest that mitoxantrone reduces collagen synthesis by inhibiting TGF-β/SMAD signaling and LARP6 expression in fibroblasts, which can be developed as a therapeutic agent for diseases caused by collagen hypersynthesis.
Insights
Mitoxantrone reduces collagen synthesis in fibroblasts by inhibiting key signaling pathways and gene expression. This finding suggests its potential as a therapeutic for conditions involving excessive collagen production.
Area of Science:
- Dermatology
- Molecular Biology
- Biochemistry
Background:
- Fibroblasts are crucial for skin structure through collagen production.
- Imbalances in collagen synthesis, either decreased or excessive, lead to skin conditions like atrophy, wrinkles, and scars.
Purpose of the Study:
- To elucidate the mechanism by which mitoxantrone influences collagen synthesis in fibroblasts.
Main Methods:
- Fibroblasts were cultured and treated with mitoxantrone.
- Collagen synthesis was assessed using reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis.
- Collagen gel contraction assays were performed to evaluate functional effects.
Main Results:
- Mitoxantrone suppressed type I collagen expression at both mRNA and protein levels.
- The drug significantly inhibited collagen gel contraction.
- Mitoxantrone interfered with transforming growth factor-beta (TGF-β)-induced SMAD3 phosphorylation and reduced LARP6 expression.
Conclusions:
- Mitoxantrone mitigates collagen synthesis by inhibiting TGF-β/SMAD signaling and downregulating LARP6 in fibroblasts.
- These mechanisms position mitoxantrone as a potential therapeutic for diseases characterized by collagen overproduction.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

